Skip to main content
. 2017 Sep 15;44(5):370–377. doi: 10.5999/aps.2017.44.5.370

Fig. 2. Viability changes in composite grafts.

Fig. 2.

Over time, the area of central necrosis was demarcated, and composite grafts injected with ADSCs in groups 1 and 2 retained significant viability when compared to the control group (P<0.05). ADSC, adipose-derived stem cell; POD, postoperative day.